Dec19

Forward progress and future goals: End of the year reflections from the IMPT

Thursday, 19 December 2019 Written by // IMPT Secretariat Staff Tags // contraceptive, innovation, prevention, product development, women

The IMPT offices are always a buzz with activity during the months of November and December. Giving Tuesday, World AIDS Day, as well as general end-of-the year wrap ups—it is a reminder that for organizations like ours, this time of year is a time for increased activism, awareness, and reflection. This year, as the IMPT celebrates a decade of progress in the MPT field, we recognize both forward progress and future goals as we continually work to bring MPTs closer to a reality that will improve the lives of women and girls worldwide.

Nov20

The IMPT develops strategies to advance non-hormonal MPTs

Wednesday, 20 November 2019 Written by // IMPT Secretariat Staff Tags // contraceptives, MPTs, non-hormonal contraceptives, prevention, product development

In 1960, FDA approval of the first hormonal contraceptive—more commonly known as “the pill”—revolutionized sexual and reproductive health, giving women unprecedented control over their fertility for the first time in history. Today, there are a range of contraceptive products available to women across the globe. Of the over 30 MPTs in the product development pipeline, 18 have a contraceptive component combined with protection against select sexually transmitted infections (STIs), including HIV, herpes simplex virus (HSV), and chlamydia. Still, women around the world need more choices. As a woman’s needs change and evolve over her lifespan, having a suite of product options for protection against unplanned pregnancy, HIV, and other STIs remains critical.

Oct31

What are we waiting for? Challenges of developing male birth control and MPTs

Thursday, 31 October 2019 Written by // Male Contraceptive Initiative

Male Contraceptive Initiative (MCI) and the Initiative for Multipurpose Prevention Technologies (IMPT) share similar missions and challenges—as well as some product overlap. Both organizations understand the importance of innovative, impactful products for men, women, their families, and the world.

[12 3 4 5  >>  

Recent Posts

Any thoughts? Contact us to learn more about the submission process.
The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
© Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.